Association of DNA base-excision repair XRCC1, OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 9, 2013, Pages 5145-5151

  Li, Qing ^a   Wang, Jian Min ^a   Peng, Yu ^a   Zhang, Shi Heng ^a   Ren, Tao ^a   Luo, Hao ^a   Cheng, Yi ^a   Wang, Dong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Base excision repair; Nasopharyngeal carcinoma (NPC); Single nucleotide polymorphisms (SNP)

Indexed keywords

APEX1 PROTEIN, HUMAN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA BINDING PROTEIN; DNA GLYCOSYLTRANSFERASE; OXOGUANINE GLYCOSYLASE 1, HUMAN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CASE CONTROL STUDY; CHINA; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; PROTECTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICAL MODEL;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CASE-CONTROL STUDIES; CHINA; DNA GLYCOSYLASES; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTECTIVE FACTORS; SMOKING;

EID: 84887576653     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.9.5145     Document Type: Article

References (49)

1. Campalans A, Marsin S, Nakabeppu Y, et al (2005). XRCC1 interacts with multiple DNA glycosylases: a model for its recruitment to base excision repair. DNA Repair, 4, 826-35.
2. Cho EY, Hildesheim A, Chen CJ, et al (2003). Nasopharyngeal Carcinoma and Genetic Polymorphisms of DNA Repair Enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev, 12, 1100-4.
3. Laantri N, Jalbout M, Khyatti M, et al (2011).XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries. Mol Carcinog, 50, 732-7.
4. Duell EJ, Holly EA, Bracci PM, et al (2002). A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res, 62, 4630-6.
5. Fachiroh J, Sangrajrang S, Johansson M, et al (2012). Tobacco consumption and genetic susceptibility to nasopharyngeal carcinoma (NPC) in Thailand. Cancer Causes Control, 23, 1995-2002.
6. Farkasova T, Gurska S, Witkovsky V, Gabelova A (2008). Significance of amino acid substitution variants of DNA repair genes in radiosusceptibility of cervical cancer patients; a pilot study. Neoplasma, 55, 330-7.
7. Hamajima N (2001). PCR-CTPP: a new genotyping technique in the era of genetic epidemiology. Expert Rev Mol Diagn, 1, 119-23.
8. Hatt L, Loft S, Risom L, et al (2008). OGG1 expression and OGG1 Ser326Cys polymorphism and risk of lung cancer in a prospective study. Mutat Res, 639, 45-54.
9. Hoeijmakers JH (2001). Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-74.
10. Huang GL, Guo HQ, Yu CY, et al (2011). XRCC1 polymorphisms and risk of nasopharyngeal carcinoma: a meta-analysis. Asian Pac J Cancer Prev, 12, 2329-33.
11. Hu JJ, Smith TR, Miller MS, et al (2001). Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis, 22, 917-22.
12. Hu JJ, Smith TR, Miller MS, et al (2002). Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen, 39, 208-15.
13. Hung RJ, Hall J, Brennan P, Boffetta P (2005). Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol, 162, 925-42.
14. Hu Z, Ma H, Chen F, et al (2005). XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev, 14, 1810-8.
15. Ji MF, Wang DK, Yu YL, et al (2007). Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br J Cancer, 96, 623-30.
16. Karahalil B, Engin AB, Coskun E (2012). Could 8-oxoguanine DNA glycosylase1 Ser326Cys polymorphism be a biomarker of susceptibility in cancer? Toxicol Ind Health.
17. Krokan HE, Nilsen H, Skorpen F, et al (2000). Base excision repair of DNA in mammalian cells. FEBS Lett, 476, 73-7.
18. Ladiges WC (2006). Mouse models of XRCC1 DNA repair polymorphisms and cancer. Oncogene, 25, 1612-9.
19. Lee A, Foo W, Mang O, et al (2003). Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-1999): an encouraging reduction in both incidence and mortality. Int J Cancer, 103, 680-5.
20. Lei YC, Hwang SJ, Chang CC, et al (2002). Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat Res, 519, 93-101.
21. Leng S, Cheng J, Zhang L, et al (2005). The association of XRCC1 haplotypes and chromosomal damage levels in peripheral blood lymphocyte among coke-oven workers. Cancer Epidemiol Biomarkers Prev, 14, 1295-301.
22. Lin TM, Chang HJ, Chen CJ, et al (1986). Risk factors for nasopharyngeal carcinoma. Anticancer Res, 6, 791-6.
23. Li Z, Guan W, Li MX, et al (2011). Genetic polymorphism of DNA base-excision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population. Arch Med Res, 42, 226-34.
24. Loft S, Svoboda P, Kasai H, et al (2006). Prospective study of 8-oxo-7, 8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer. Carcinogenesis, 27, 1245-50.
25. Maynard S, Schurman SH, Harboe C, et al (2009). Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis, 30, 2-10.
26. Nakao M, Hosono S, Ito H, et al (2012). Selected polymorphisms of base excision repair genes and pancreatic cancer risk in Japanese. J Epidemiol, 22, 477-83.
27. Palli D, Russo A, Masala G, et al (2001). DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int J Cancer, 94, 121-7.
28. Pampel FC (2003). Declining sex differences in mortality from lung cancer in high-income nations. Demography, 40, 45-65.
29. Park JY, Lee SY, Jeon HS, et al (2002). Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev, 11, 23-7.
30. Pastorelli R, Cerri A, Mezzetti M, et al (2002). Effect of DNA repair gene polymorphisms on BPDEDNA adducts in human lymphocytes. Int J Cancer, 100, 9-13.
31. Petermann E, Keil C, Oei SL (2006). Roles of DNA ligase III and XRCC1 in regulating the switch between short patch and long patch BER. DNA Repair (Amst), 5, 544-55.
32. Qu T, Morimoto K (2005). X-ray repair cross-complementing group 1 polymorphisms and cancer risks in Asian populations: a mini review. Cancer Detect Prev, 29, 215-20.
33. Ratnasinghe LD, Abnet C, Qiao YL, et al (2004). Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. Cancer Lett, 216, 157-64.
34. Robertson AB, Klungland A, Rognes T, Leiros I (2009). DNA repair in mammalian cells: base excision repair: the long and short of it. Cell Mol Life Sci, 66, 981-93.
35. Skinner DW, VanHasselt CA, Tsao SY (1991). Nasopharyngeal carcinoma: modes of presentation. Ann Otol Rhinol Laryngol, 100, 544-51.
36. Shen M, Hung RJ, Brennan P, et al (2003). Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in Northern Italy. Cancer Epidemiol Biomarkers Prev, 12, 1234-40.
37. Smith TR, Levine EA, Perrier ND, et al (2003). DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 12, 1200-4.
38. Stern MC, Umbach DM, van Gils CH, et al (2001). DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev, 10, 125-31.
39. Sturgis EM, Castillo EJ, Li L, et al (1999). Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis, 20, 2125-9.
40. Tell G, Damante G, Caldwell D, Kelley MR (2005). The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal, 7, 367-84.
41. Tudek B (2007). Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med, 28, 258-75.
42. Tuimala J, Szekely G, Gundy S, et al (2002). Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis, 23, 1003-8.
43. Wei Q, Cheng L, Hong WK, Spitz MR (1996). Reduced DNA repair capacity in lung cancer patients. Cancer Res, 56, 4103-7.
44. Wood RD, Mitchell M, Sgouros J, Lindahl T (2001). Human DNA repair genes. Science, 291, 1284-9.
45. Xi T, Jones IM, Mohrenweiser HW (2004). Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics, 83, 970-9.
46. Yuan JM, Wang XL, Xiang YB, et al (2000). Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai, China. Int J Cancer, 85, 364-9.
47. Yuan JM, Wang XL, Xiang YB, et al (2000). Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer, 85, 358-63.
48. Yun Cao, Xiao-Ping Miao, et al (2006). Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population, BMC Cancer, 6, 167.
49. Zhu K, Levine RS, Brann EA, et al (1995). A populationbased case-control study of the relationship between cigarette smoking and nasopharyngeal cancer (United States). Cancer Causes Control, 6, 507-12.